Previous Close | 76.01 |
1-Year Change | -29.13% |
6-Months Change | -0.11% |
3-Months Change | 13.16% |
Moving Avg (50d) | 70.381 |
Moving Avg (200d) | 80.826 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.34B |
Beta (3-Years) | 1.17 |
Revenue Growth (ttm) | 9.36% |
Net Profit Margin (ttm) | 4.96% |
Return On Assets (ttm) | 2.49% |
EPS (ttm) | 1.9 |
PE Ratio (ttm) | 40.01 |
Dividend Yield | 0.79% |
Asset Description: | CONMED Corporation |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
77.53 | 79.811 | 81.331 | 83.611 | 87.412 | 91.212 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.